I agree that this site is using cookies. You can find further informations here.
X
Leaney, Joanne L.
28  results:
Search for persons X
?
1

2893 A. Efficacy and Safety of Aztreonam-Avibactam for the ..:

Carmeli, Yehuda ; Cisneros, Jose-Miguel ; Paul, Mical...
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
2

Clinical Pharmacology Perspectives on the Antiviral Activit..:

Damle, Bharat ; Vourvahis, Manoli ; Wang, Erjian..
Clinical Pharmacology & Therapeutics.  108 (2020)  2 - p. 201-211 , 2020
Link: https://doi.org/10.1002/..
 
?
3

Translation of blood pressure and heart rate effects betwee..:

Adeyemi, Oladipupo ; Harris, Peter D. ; Leaney, Joanne.
Journal of Pharmacological and Toxicological Methods.  64 (2011)  1 - p. e34 , 2011
Link: https://doi.org/10.1016/..
 
?
4

Cardiovascular profiles of beta3 agonists:

Leaney, Joanne L. ; Roberts, Sonia ; Harris, Jolie...
Journal of Pharmacological and Toxicological Methods.  62 (2010)  2 - p. e26 , 2010
Link: https://doi.org/10.1016/..
 
?
5

Investigating dynamic protocol-dependence of hERG potassium..:

Milnes, James T. ; Witchel, Harry J. ; Leaney, Joanne L...
Journal of Pharmacological and Toxicological Methods.  61 (2010)  2 - p. 178-191 , 2010
Link: https://doi.org/10.1016/..
 
?
6

Impact of study design on proarrhythmia prediction in the S..:

Steidl-Nichols, Jill V. ; Hanton, Gilles ; Leaney, Joanne...
Journal of Pharmacological and Toxicological Methods.  57 (2008)  1 - p. 9-22 , 2008
Link: https://doi.org/10.1016/..
 
?
7

Towards automation of a valuable preclinical cardiac safety..:

Lightbown, Ian D. ; Johnson, Mark ; Davis, Anne..
Journal of Pharmacological and Toxicological Methods.  56 (2007)  2 - p. 194-202 , 2007
Link: https://doi.org/10.1016/..
 
?
8

IMPACT OF EXPERIMENTAL DESIGN AND PK/PD MODELING ON SAFETY ..:

Dewhurst, Mark ; Brunton, Neil ; Leaney, Joanne L...
Journal of Pharmacological and Toxicological Methods.  56 (2007)  2 - p. e71 , 2007
Link: https://doi.org/10.1016/..
 
?
9

Mechanism of hERG K+ channel blockade by the fluoroquinolon..:

Alexandrou, Ari J ; Duncan, Rona S ; Sullivan, Anneli...
British Journal of Pharmacology.  147 (2006)  8 - p. 905-916 , 2006
Link: https://doi.org/10.1038/..
 
?
10

Erythromycin block of the HERG K+ channel: Accessibility to..:

Duncan, Rona S. ; Ridley, John M. ; Dempsey, Christopher E....
Biochemical and Biophysical Research Communications.  341 (2006)  2 - p. 500-506 , 2006
Link: https://doi.org/10.1016/..
 
?
11

Differential Phosphoinositide Binding to Components of the ..:

Thomas, Alison M. ; Brown, Sean G. ; Leaney, Joanne L..
Journal of Membrane Biology.  211 (2006)  1 - p. 43-53 , 2006
Link: https://doi.org/10.1007/..
 
?
12

hERG K+ channel blockade by the antipsychotic drug thiorida..:

Milnes, James T. ; Witchel, Harry J. ; Leaney, Joanne L...
Biochemical and Biophysical Research Communications.  351 (2006)  1 - p. 273-280 , 2006
Link: https://doi.org/10.1016/..
 
?
13

Contribution of Kir3.1, Kir3.2A and Kir3.2C subunits to nat..:

Leaney, Joanne L.
European Journal of Neuroscience.  18 (2003)  8 - p. 2110-2118 , 2003
Link: https://doi.org/10.1046/..
 
?
14

Agonist Unbinding from Receptor Dictates the Nature of Deac..:

Benians, Amy ; Leaney, Joanne L. ; Tinker, Andrew
Proceedings of the National Academy of Sciences of the United States of America.  100 (2003)  10 - p. 6239-6244 , 2003
Link: https://www.jstor.org/st..
 
?
15

Agonist unbinding from receptor dictates the nature of deac..:

Benians, Amy ; Leaney, Joanne L. ; Tinker, Andrew
Proceedings of the National Academy of Sciences.  100 (2003)  10 - p. 6239-6244 , 2003
Link: https://doi.org/10.1073/..
 
1-15